Company / Profit Margin
OCULAR THERAPEUTIX, INC Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-511.9%
FY2025
5-year range
-2043.3% / -138.1%
FY2021-FY2025
Trend
-68.6%
vs FY2024
Sector context
#123 of 145
Health Care
What the data says
OCULAR THERAPEUTIX, INC's profit margin of -511.9% is lower than 85% of companies in the Health Care sector (FY2025). Profit Margin has fluctuated over the past 10 years, ranging from -3296.2% in FY2019 to -138.1% in FY2023.
Based on SEC 10-K filings.
-511.9% in FY2025 with a 5-year CAGR of +1531.4%.
Declined from -138.1% to -511.9% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +382.4pp
- 5-Year Change
- +1531.4pp
- 10-Year Change
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 145This company -511.9% Sector average -792.7%
▼
+35.4% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 68.6% year-over-year.
- Currently 280.8pp above the Health Care sector average.
- Peak profit margin was recorded in FY2023.
- Lowest profit margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -511.9% | -68.6% |
| FY2024 | -303.7% | -119.8% |
| FY2023 | -138.1% | +84.6% |
| FY2022 | -894.3% | +56.2% |
| FY2021 | -2043.3% | +0.0% |
| FY2020 | -2043.3% | +38.0% |
| FY2019 | -3296.2% | -9.4% |
| FY2018 | -3014.0% | +8.6% |
| FY2017 | -3296.2% | -39.1% |
| FY2016 | -2369.0% | -37.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026